Crossmark

Tumor budding in pre-neoadjuvant biopsy and post-neoadjuvant resection specimens is associated with poor prognosis in intrahepatic cholangiocarcinoma—a cohort study of 147 cases by modified ITBCC criteria

Crossref DOI link: https://doi.org/10.1007/s00428-024-03937-y

Published Online: 2024-10-10

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Gaohua

Luo, Rongkui

Xu, Qianhui

Yang, Liuxiao

Xia, Hongping

Chew, Valerie

Koh, Ye Xin

Chang, Kenneth Tou En

Zhou, Jian

Fan, Jia

Gao, Qiang

Shi, Ruoyu

Zhu, Kai https://orcid.org/0009-0003-8401-7124
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82150004)

Natural Science Foundation of Shanghai Municipality (21ZR1413800)

the Clinical Research Plan of SHDC (SHDC2020CR1022B)
License Information

Text and Data Mining valid from 2024-10-10

Version of Record valid from 2024-10-10
More Information

Article History

Received: 15 July 2024

Revised: 30 August 2024

Accepted: 29 September 2024

First Online: 10 October 2024

Declarations

:

: This study was approved by the Zhongshan Hospital Research Ethics Committee Research Ethics Committee and complied with all ethical regulations (Approval ID: B2023-321, IRB number: IRB00014212).

: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Document is current

Any future updates will be listed below